MedTrace Logo

Cardiovascular Intervention Improvement Telemedicine Study

NCT01142908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 428

Last updated 2023-07-27

Study results available
· View outcomes & findings →

Summary

Cardiovascular disease (CVD) is the leading cause of death in the United States; more than 80% of veterans have \> 2 risk factors for CVD. Our study is one of the first to examine the implementation of a tailored behavioral/educational self-management intervention in primary care clinics designed to improve CVD risk. The proposed study could result in a leap forward in CVD risk management among veterans for several reasons: 1) ) This is a novel extension of our previous interventions that have demonstrated improved BP, now designed to address multiple chronic conditions contributing to CVD risk, particularly hyperlipidemia and diabetes. The study focuses on both multiple CVD-related risk factor management and medication management 2) The intervention is multi-behavioral; it addresses patients' various health behavior (e.g., smoking, diet, and medication adherence). 3) Components of the intervention will include specific recommendations and transportability of intervention application software and tracking packages that will allow clinic managers to implement the intervention if it is effective.

Conditions

Interventions

BEHAVIORAL

Pharmacist CVD

clinical pharmacist-administered intervention which focuses on behavioral and medication management for 12 months.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Hayden B Bosworth, PhD · Durham VA Medical Center, Durham, NC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-01
Primary Completion
2015-04-30
Completion
2015-05-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142908 on ClinicalTrials.gov